E-LIB Suche - Ergebnisse für: Strickler, John

1

Sotorasib with panitumumab in chemotherapy-refractory KRASG..:

Kuboki, Yasutoshi ; Fakih, Marwan ; Strickler, John...
Nature Medicine. 30 (2024) 1 - p. 265-270 , 2024

Link: https://doi.org/10.1038/..

2

ASO Visual Abstract: Trends in Receipt of Adjuvant Chemothe..:

Rhodin, Kristen E. ; Liu, Annie ; Bartholomew, Alex...
Annals of Surgical Oncology. 30 (2023) 8 - p. 4824-4825 , 2023

Link: https://doi.org/10.1245/..

3

Trends in Receipt of Adjuvant Chemotherapy and its Impact o..:

Rhodin, Kristen E. ; Liu, Annie ; Bartholomew, Alex...
Annals of Surgical Oncology. 30 (2023) 8 - p. 4813-4821 , 2023

Link: https://doi.org/10.1245/..

4

A quality improvement initiative to increase genetic testin..:

Peters, Pamela ; Gonzalez, Rafael ; Havrilesky, Laura...
Gynecologic Oncology. 166 (2022) - p. S152 , 2022

Link: https://doi.org/10.1016/..

5

A randomized phase II trial of nab‐paclitaxel and gemcitabi..:

Hu, Zishuo Ian ; Bendell, Johanna C. ; Bullock, Andrea...
Cancer Medicine. 8 (2019) 11 - p. 5148-5157 , 2019

Link: https://doi.org/10.1002/..

6

MA09.09 First-In-Human Phase 1 Study of ABBV-399, an Antibo..:

Angevin, Eric ; Strickler, John ; Weekes, Colin...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S395-S396 , 2017

Link: https://doi.org/10.1016/..

7

Safety, pharmacokinetics, and pharmacodynamic properties of..:

Hurwitz, Herbert I. ; Smith, David C. ; Pitot, Henry C....
Cancer Chemotherapy and Pharmacology. 75 (2015) 4 - p. 851-859 , 2015

Link: https://doi.org/10.1007/..

8

Trastuzumab-Deruxtecan: Redefining HER2 as a Tumor Agnostic..:

Zouein, Joseph ; Karam, Elias ; Strickler, John H..
Targeted Oncology. , 2024

Link: https://doi.org/10.1007/..

9

A Study to Learn how Well Tucatinib Plus Trastuzumab Works ..:

Strickler, John H ; Bekaii-Saab, Tanios S
Future Oncology. 20 (2024) 8 - p. 409-421 , 2024

Link: https://doi.org/10.2217/..

10

Racial and ethnic disparities in genomic testing among lung..:

Meernik, Clare ; Raveendran, Yadurshini ; Kolarova, Michaela...
JNCI: Journal of the National Cancer Institute. 116 (2024) 6 - p. 812-828 , 2024

Link: https://doi.org/10.1093/..

11

Trastuzumab deruxtecan in patients with HER2-positive advan..:

Raghav, Kanwal ; Siena, Salvatore ; Takashima, Atsuo...
The Lancet Oncology. , 2024

Link: https://doi.org/10.1016/..

12

Prevalence of KRAS G12C Mutation and Co-mutations and Assoc..:

Strickler, John H ; Yoshino, Takayuki ; Stevinson, Kendall...
The Oncologist. 28 (2023) 11 - p. e981-e994 , 2023

Link: https://doi.org/10.1093/..

13

Hepatic artery infusion for unresectable colorectal cancer ..:

Zaidi, Mohammad Y. ; Nussbaum, Daniel P. ; Hsu, Shiaowen David...
Surgery. 174 (2023) 2 - p. 428-430 , 2023

Link: https://doi.org/10.1016/..

14

Impact of Anti-EGFR Therapies on HER2-Positive Metastatic C..:

Bekaii-Saab, Tanios S ; Lach, Krzysztof ; Hsu, Ling-I...
The Oncologist. 28 (2023) 10 - p. 885-893 , 2023

Link: https://doi.org/10.1093/..

15

Targeting KRAS-Mutated Gastrointestinal Malignancies with S..:

Caughey, Bennett A. ; Strickler, John H.
Drugs. 84 (2023) 1 - p. 27-44 , 2023

Link: https://doi.org/10.1007/..